Indeed, in previous work by Feng et al.29, CD206+/CD68+ ratio was shown to be a better prognostic biomarker than CD68+ or CD206+ cell density for disease-free survival and overall survival in stage II colon cancer. The gene discussed is MRC1; the disease is colonic neoplasm.